n-methyl-3,4-methylenedioxyamphetamine has been researched along with p-chloroamphetamine in 30 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (13.33) | 18.7374 |
| 1990's | 14 (46.67) | 18.2507 |
| 2000's | 8 (26.67) | 29.6817 |
| 2010's | 4 (13.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Butler, SG; Cloonan, SM; Corrigan, D; Jørgensen, AM; Keating, JJ; Knox, AJ; Lloyd, DG; Meegan, MJ; Peters, GH; Rai, D; Williams, DC | 1 |
| Azmitia, EC; Berger, UV; Gu, XF | 1 |
| Farfel, GM; Seiden, LS; Vosmer, GL | 1 |
| Conarty, PF; Johnson, MP; Nichols, DE | 1 |
| Black, CK; Schmidt, CJ; Taylor, VL | 2 |
| Huang, XM; Johnson, MP; Nash, JF; Nichols, DE; Oberlender, R | 1 |
| Cho, AK; Hiramatsu, M; Kameyama, T; Maeda, Y; Nabeshima, T | 1 |
| Cho, AK; Gazzara, RA; Howard, SG; Takeda, H | 1 |
| Ali, SF; Bailey, JR; Holson, RR; Hong, JS; Kolta, MG; McMillan, DE; Paule, MG; Scallet, AC; Scalzo, FM; Slikker, W | 1 |
| Levin, JA; Lovenberg, W; Schmidt, CJ | 1 |
| Cowen, PJ; Series, HG; Sharp, T | 1 |
| Colado, MI; Green, AR; Murray, TK | 1 |
| Rudnick, G; Schuldiner, S; Steiner-Mordoch, S; Wall, SC; Yelin, R | 1 |
| Azmitia, EC; Gu, XF | 1 |
| Johnson, MP; Nichols, DE; Schmidt, CJ; Sprague, JE | 1 |
| Colado, MI; Granados, R; Green, AR; Murray, TK; O'Shea, E | 1 |
| Crespi, D; Gobbi, M; Mennini, T | 1 |
| Azmitia, EC; Kramer, HK; Poblete, JC | 1 |
| Ceglia, I; Gobbi, M; Mennini, T; Moia, M; Pirona, L; Reyes-Parada, M; Scorza, C | 1 |
| Anderson, KL; Itzhak, Y | 1 |
| Achat-Mendes, CN; Ali, SF; Anderson, KL; Itzhak, Y | 1 |
| Dowgiert, J; Francescutti-Verbeem, D; Geddes, TJ; Kuhn, DM; Liu, X; Thomas, DM | 1 |
| Hatzidimitriou, G; McCann, U; McLane, MW; Ricaurte, G; Tong, L; Xie, T; Yuan, J | 1 |
| Colado, MI; Elliott, JM; Green, AR; Saadat, KS | 1 |
| Büchler, J; Kovar, KA; Putzke, J; Smalla, KH; Spina, MG; Wolf, G | 1 |
| Fantegrossi, WE; Finton, BJ; Galloway, MP; Howell, LL; Murnane, KS; Perrine, SA | 1 |
| Boehm, S; Freissmuth, M; Gerstbrein, K; Koenig, X; Mayer, FP; Sandtner, W; Schicker, K; Schmid, D; Sitte, HH | 1 |
| Bulusu, S; Freissmuth, M; Koenig, X; Sandtner, W; Schicker, K; Schmid, D; Sitte, HH | 1 |
| Cameron, KN; De Felice, LJ | 1 |
30 other study(ies) available for n-methyl-3,4-methylenedioxyamphetamine and p-chloroamphetamine
| Article | Year |
|---|---|
Synthesis and serotonin transporter activity of sulphur-substituted alpha-alkyl phenethylamines as a new class of anticancer agents.
Topics: Amphetamines; Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Humans; Inhibitory Concentration 50; Models, Molecular; Molecular Structure; Phenethylamines; Serotonin Plasma Membrane Transport Proteins; Structure-Activity Relationship; Sulfur | 2009 |
The substituted amphetamines 3,4-methylenedioxymethamphetamine, methamphetamine, p-chloroamphetamine and fenfluramine induce 5-hydroxytryptamine release via a common mechanism blocked by fluoxetine and cocaine.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamines; Animals; Calcium; Cocaine; Fenfluramine; Fluoxetine; In Vitro Techniques; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; p-Chloroamphetamine; Potassium Chloride; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Serotonin; Serotonin Antagonists; Synaptosomes | 1992 |
The N-methyl-D-aspartate antagonist MK-801 protects against serotonin depletions induced by methamphetamine, 3,4-methylenedioxymethamphetamine and p-chloroamphetamine.
Topics: 3,4-Methylenedioxyamphetamine; Animals; Corpus Striatum; Dizocilpine Maleate; Hippocampus; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; N-Methylaspartate; p-Chloroamphetamine; Rats; Serotonin | 1992 |
[3H]monoamine releasing and uptake inhibition properties of 3,4-methylenedioxymethamphetamine and p-chloroamphetamine analogues.
Topics: 3,4-Methylenedioxyamphetamine; Animals; Designer Drugs; Dopamine; Male; N-Methyl-3,4-methylenedioxyamphetamine; Neurotransmitter Uptake Inhibitors; Norepinephrine; p-Chloroamphetamine; Rats; Rats, Inbred Strains; Regression Analysis; Reserpine; Serotonin; Synaptosomes | 1991 |
L-DOPA potentiation of the serotonergic deficits due to a single administration of 3,4-methylenedioxymethamphetamine, p-chloroamphetamine or methamphetamine to rats.
Topics: 3,4-Methylenedioxyamphetamine; Animals; Brain Chemistry; Cerebral Cortex; Corpus Striatum; Dopamine; Drug Synergism; Fenfluramine; Hippocampus; Levodopa; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Nerve Degeneration; Nerve Endings; Nervous System Diseases; p-Chloroamphetamine; Rats; Rats, Inbred Strains; Serotonin | 1991 |
Antagonism of the neurotoxicity due to a single administration of methylenedioxymethamphetamine.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamines; Animals; Aromatic Amino Acid Decarboxylase Inhibitors; Biogenic Monoamines; Brain; Catecholamines; Hydroxydopamines; Indoles; Male; N-Methyl-3,4-methylenedioxyamphetamine; Nervous System Diseases; Oxidopamine; p-Chloroamphetamine; Rats; Rats, Inbred Strains; Reserpine; Serotonin; Substantia Nigra; Tryptophan Hydroxylase | 1990 |
Behavioral, biochemical and neurotoxicological actions of the alpha-ethyl homologue of p-chloroamphetamine.
Topics: 3,4-Methylenedioxyamphetamine; Animals; Behavior, Animal; Biological Transport, Active; Brain; Discrimination Learning; Dopamine; Male; N-Methyl-3,4-methylenedioxyamphetamine; Nervous System; p-Chloroamphetamine; Rats; Rats, Inbred Strains; Serotonin | 1990 |
The effect of optical isomers of 3,4-methylenedioxymethamphetamine (MDMA) on stereotyped behavior in rats.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamines; Animals; Behavior, Animal; Dose-Response Relationship, Drug; Male; N-Methyl-3,4-methylenedioxyamphetamine; p-Chloroamphetamine; Rats; Rats, Inbred Strains; Stereoisomerism; Stereotyped Behavior; Time Factors | 1989 |
Inhibition of dopamine release by methylenedioxymethamphetamine is mediated by serotonin.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamines; Animals; Cerebral Cortex; Corpus Striatum; Dopamine; Male; N-Methyl-3,4-methylenedioxyamphetamine; Neurotransmitter Agents; p-Chloroamphetamine; Rats; Rats, Inbred Strains; Serotonin | 1989 |
Behavioral and neurochemical effects of orally administered MDMA in the rodent and nonhuman primate.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamines; Animals; Behavior, Animal; beta-Endorphin; Biogenic Monoamines; Brain Chemistry; Conditioning, Operant; Female; Macaca mulatta; Male; N-Methyl-3,4-methylenedioxyamphetamine; p-Chloroamphetamine; Radioimmunoassay; Rats; Rats, Inbred Strains; Reaction Time; Reflex, Startle; Sex Factors | 1989 |
In vitro and in vivo neurochemical effects of methylenedioxymethamphetamine on striatal monoaminergic systems in the rat brain.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamines; Animals; Citalopram; Corpus Striatum; Dopamine; In Vitro Techniques; Male; N-Methyl-3,4-methylenedioxyamphetamine; p-Chloroamphetamine; Propylamines; Rats; Rats, Inbred Strains; Serotonin; Stereoisomerism | 1987 |
p-Chloroamphetamine (PCA), 3,4-methylenedioxy-methamphetamine (MDMA) and d-fenfluramine pretreatment attenuates d-fenfluramine-evoked release of 5-HT in vivo.
Topics: Amphetamines; Animals; Cerebral Cortex; Chromatography, High Pressure Liquid; Dextroamphetamine; Fenfluramine; Hydroxyindoleacetic Acid; Male; Microdialysis; N-Methyl-3,4-methylenedioxyamphetamine; p-Chloroamphetamine; Potassium; Raphe Nuclei; Rats; Rats, Sprague-Dawley; Serotonin | 1994 |
5-HT loss in rat brain following 3,4-methylenedioxymethamphetamine (MDMA), p-chloroamphetamine and fenfluramine administration and effects of chlormethiazole and dizocilpine.
Topics: 3,4-Methylenedioxyamphetamine; Animals; Behavior, Animal; Body Temperature; Brain Chemistry; Cerebral Cortex; Chlormethiazole; Dizocilpine Maleate; Fenfluramine; Hippocampus; Hydroxyindoleacetic Acid; Male; N-Methyl-3,4-methylenedioxyamphetamine; p-Chloroamphetamine; Rats; Serotonin | 1993 |
Amphetamine derivatives interact with both plasma membrane and secretory vesicle biogenic amine transporters.
Topics: 3,4-Methylenedioxyamphetamine; Animals; Blood Platelets; Carrier Proteins; Cattle; Cell Membrane; Chromaffin Granules; Fenfluramine; Humans; In Vitro Techniques; Membrane Glycoproteins; Membrane Transport Proteins; N-Methyl-3,4-methylenedioxyamphetamine; Nerve Tissue Proteins; p-Chloroamphetamine; Reserpine; Serotonin; Serotonin Plasma Membrane Transport Proteins | 1993 |
Integrative transporter-mediated release from cytoplasmic and vesicular 5-hydroxytryptamine stores in cultured neurons.
Topics: 3,4-Methylenedioxyamphetamine; Animals; Brain Stem; Carrier Proteins; Cells, Cultured; Clorgyline; Female; Fluoxetine; Membrane Glycoproteins; Membrane Transport Proteins; N-Methyl-3,4-methylenedioxyamphetamine; Nerve Tissue Proteins; Neurons; Nimodipine; p-Chloroamphetamine; Pregnancy; Rats; Rats, Sprague-Dawley; Reserpine; Selegiline; Serotonin; Serotonin Plasma Membrane Transport Proteins | 1993 |
Studies on the mechanism of p-chloroamphetamine neurotoxicity.
Topics: Animals; Brain; Clorgyline; Dopamine; Fever; Hydroxyindoleacetic Acid; Indans; Male; Monoamine Oxidase Inhibitors; N-Methyl-3,4-methylenedioxyamphetamine; Neuroprotective Agents; Neurotoxins; p-Chloroamphetamine; Paroxetine; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Selegiline; Serotonin; Serotonin Agents | 1996 |
In vivo evidence for free radical involvement in the degeneration of rat brain 5-HT following administration of MDMA ('ecstasy') and p-chloroamphetamine but not the degeneration following fenfluramine.
Topics: Animals; Biogenic Monoamines; Body Temperature; Brain Chemistry; Fenfluramine; Free Radical Scavengers; Free Radicals; Hippocampus; Male; Microdialysis; N-Methyl-3,4-methylenedioxyamphetamine; Nerve Degeneration; p-Chloroamphetamine; Paroxetine; Rats; Selective Serotonin Reuptake Inhibitors; Serotonin Agents | 1997 |
Carrier-dependent and Ca(2+)-dependent 5-HT and dopamine release induced by (+)-amphetamine, 3,4-methylendioxymethamphetamine, p-chloroamphetamine and (+)-fenfluramine.
Topics: Amphetamine; Animals; Calcium; Carrier Proteins; Dopamine; Fenfluramine; Male; Methiothepin; N-Methyl-3,4-methylenedioxyamphetamine; Neurotransmitter Uptake Inhibitors; p-Chloroamphetamine; Rats; Rats, Sprague-Dawley; Serotonin | 1997 |
Characterization of the translocation of protein kinase C (PKC) by 3,4-methylenedioxymethamphetamine (MDMA/ecstasy) in synaptosomes: evidence for a presynaptic localization involving the serotonin transporter (SERT).
Topics: Animals; Calcium; Cerebral Cortex; Female; N-Methyl-3,4-methylenedioxyamphetamine; p-Chloroamphetamine; Protein Kinase C; Rats; Rats, Sprague-Dawley; Serotonin Agents; Synaptosomes | 1998 |
p-Methylthioamphetamine and 1-(m-chlorophenyl)piperazine, two non-neurotoxic 5-HT releasers in vivo, differ from neurotoxic amphetamine derivatives in their mode of action at 5-HT nerve endings in vitro.
Topics: Amphetamines; Animals; Binding, Competitive; Brain Chemistry; Carrier Proteins; Citalopram; Dose-Response Relationship, Drug; Hippocampus; Membrane Glycoproteins; Membrane Transport Proteins; Microdialysis; N-Methyl-3,4-methylenedioxyamphetamine; Nerve Endings; Nerve Tissue Proteins; p-Chloroamphetamine; Piperazines; Rats; Serotonin; Serotonin Agents; Serotonin Plasma Membrane Transport Proteins; Synaptosomes; Tritium | 2002 |
Inhibition of neuronal nitric oxide synthase suppresses the maintenance but not the induction of psychomotor sensitization to MDMA ('Ecstasy') and p-chloroamphetamine in mice.
Topics: Animals; Dose-Response Relationship, Drug; Enzyme Inhibitors; Indazoles; Locomotion; Male; Mice; Motor Activity; N-Methyl-3,4-methylenedioxyamphetamine; Neuronal Plasticity; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; p-Chloroamphetamine; Psychomotor Performance; Serotonin Agents; Time Factors | 2003 |
Long-lasting behavioral sensitization to psychostimulants following p-chloroamphetamine-induced neurotoxicity in mice.
Topics: Anesthetics, Local; Animals; Behavior, Animal; Binding Sites; Brain Chemistry; Carrier Proteins; Chromatography, High Pressure Liquid; Cocaine; Dopamine; Dopamine Plasma Membrane Transport Proteins; Drug Administration Schedule; Drug Interactions; Hallucinogens; Male; Membrane Glycoproteins; Membrane Transport Proteins; Mice; Motor Activity; N-Methyl-3,4-methylenedioxyamphetamine; Nerve Tissue Proteins; Neurotoxicity Syndromes; p-Chloroamphetamine; Serotonin; Serotonin Agents; Serotonin Plasma Membrane Transport Proteins; Time Factors | 2004 |
Microglial activation is a pharmacologically specific marker for the neurotoxic amphetamines.
Topics: Amphetamine; Analysis of Variance; Animals; Blotting, Western; Cell Count; Corpus Striatum; Dopamine Agents; Female; Glial Fibrillary Acidic Protein; Immunohistochemistry; Lectins; Methamphetamine; Mice; Mice, Inbred C57BL; Microglia; N-Methyl-3,4-methylenedioxyamphetamine; p-Chloroamphetamine | 2004 |
Loss of serotonin transporter protein after MDMA and other ring-substituted amphetamines.
Topics: 5,7-Dihydroxytryptamine; Animals; Axons; Brain; Down-Regulation; Fenfluramine; Immunohistochemistry; Male; N-Methyl-3,4-methylenedioxyamphetamine; Neurotoxins; p-Chloroamphetamine; Rats; Rats, Sprague-Dawley; Serotonin; Serotonin Agents; Serotonin Plasma Membrane Transport Proteins; Tryptophan Hydroxylase; Wallerian Degeneration | 2006 |
The acute and long-term neurotoxic effects of MDMA on marble burying behaviour in mice.
Topics: Animals; Dopamine; Hallucinogens; Mice; Motor Activity; N-Methyl-3,4-methylenedioxyamphetamine; p-Chloroamphetamine; Psychotropic Drugs; Serotonin; Serotonin Agents; Stereotyped Behavior | 2006 |
The effects of p-chloroamphetamine, methamphetamine and 3,4-methylenedioxymethamphetamine (ecstasy) on the gene expression of cytoskeletal proteins in the rat brain.
Topics: Actins; Animals; Blotting, Western; Brain Mapping; Central Nervous System Stimulants; Cerebral Cortex; Cytoskeletal Proteins; Dose-Response Relationship, Drug; Gene Expression; In Situ Hybridization; Injections, Intraperitoneal; Male; Methamphetamine; Microtubule-Associated Proteins; N-Methyl-3,4-methylenedioxyamphetamine; p-Chloroamphetamine; Rats; Rats, Wistar; Survival Analysis | 2007 |
Effects of exposure to amphetamine derivatives on passive avoidance performance and the central levels of monoamines and their metabolites in mice: correlations between behavior and neurochemistry.
Topics: Adrenergic Agents; Animals; Avoidance Learning; Behavior, Animal; Brain; Chromatography, High Pressure Liquid; Dopamine; Dose-Response Relationship, Drug; Linear Models; Male; Memory; Methamphetamine; Mice; N-Methyl-3,4-methylenedioxyamphetamine; p-Chloroamphetamine; Serotonin; Serotonin Agents | 2012 |
A quantitative model of amphetamine action on the 5-HT transporter.
Topics: Animals; HEK293 Cells; Humans; Models, Biological; N-Methyl-3,4-methylenedioxyamphetamine; Oocytes; p-Chloroamphetamine; Serotonin; Serotonin Agents; Serotonin Plasma Membrane Transport Proteins; Xenopus laevis | 2014 |
The conservative view: is it necessary to implant a stent into the dopamine transporter?
Topics: Animals; Humans; Models, Biological; N-Methyl-3,4-methylenedioxyamphetamine; p-Chloroamphetamine; Serotonin; Serotonin Agents; Serotonin Plasma Membrane Transport Proteins | 2015 |
Comments on 'A quantitative model of amphetamine action on the serotonin transporter', by Sandtner et al., Br J Pharmacol 171: 1007-1018.
Topics: Animals; Humans; Models, Biological; N-Methyl-3,4-methylenedioxyamphetamine; p-Chloroamphetamine; Serotonin; Serotonin Agents; Serotonin Plasma Membrane Transport Proteins | 2015 |